Christa Pawlowski, PhD
Chief Operating Officer
Dr. Christa Pawlowski has over a decade of drug discovery and development experience. Her main focus has been the development of nanoparticle-based medicines for multiple therapeutic indications including cardiovascular diseases, inflammation, immunology, and oncology. Christa has authored more than 15 research and review articles, presented at numerous international conferences, and holds several patents. Prior to joining SapVax, she co-founded Haima Therapeutics, a biotechnology company focused on the development of bio-inspired therapeutics for treating bleeding and other blood-related ailments.
Christa completed her B.S.E. and Ph.D. in Biomedical Engineering at Case Western Reserve University and was the recipient of an NSF Graduate Research Fellowship, a Medtronic Graduate Fellowship and a Baxter Young Investigator Award.